Compare · CERS vs TWTR
CERS vs TWTR
Side-by-side comparison of Cerus Corporation (CERS) and Twitter Inc. (TWTR): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CERS and TWTR operate in EDP Services (Technology), so they compete in similar markets.
- TWTR is the larger of the two at $28.20B, about 54.1x CERS ($521.0M).
- CERS has hit the wire 12 times in the past 4 weeks while TWTR has been quiet.
- TWTR has more recent analyst coverage (25 ratings vs 4 for CERS).
- Company
- Cerus Corporation
- Twitter Inc.
- Price
- $2.60-0.19%
- $53.83+0.77%
- Market cap
- $521.0M
- $28.20B
- 1M return
- -0.57%
- -
- 1Y return
- +75.68%
- -
- Industry
- EDP Services
- EDP Services
- Exchange
- NASDAQ
- NYSE
- IPO
- 1997
- 2013
- News (4w)
- 12
- 0
- Recent ratings
- 4
- 25
Cerus Corporation
Cerus Corporation, a biomedical products company, focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. Cerus Corporation has collaboration with LifeSouth Community Blood Centers to manufacture INTERCEPT Fibrinogen Complex. The company was incorporated in 1991 and is headquartered in Concord, California.
Twitter Inc.
Twitter, Inc. operates as a platform for public self-expression and conversation in real time United States, Japan, and internationally. The company offers Twitter, a platform that allows users to consume, create, distribute, and discover content. It also provides promoted products and services, such as promoted tweets, promoted accounts, and promoted trends, which enable its advertisers to promote their brands, products, and services. In addition, the company offers MoPub, a mobile-focused advertising exchange that combines ad serving, ad network mediation, and a real-time bidding exchange into one monetization platform; Twitter Audience platform, an advertising offering that enables advertisers to extend advertising campaigns; Developer and Enterprise solutions, a software-as-a-service platform that enables developers to build products on Twitter; and paid enterprise access for its public data streams. Twitter, Inc. was founded in 2006 and is headquartered in San Francisco, California.
Latest CERS
- Cerus Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation
- Cerus Corporation Closes New Debt Facility of Up to $110 Million
- Cerus Corporation filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders
- Director Lucena Ann was granted 60,000 shares, increasing direct ownership by 35% to 232,284 units (SEC Form 4)
- Director Bjerkholt Eric was granted 60,000 shares, increasing direct ownership by 27% to 282,133 units (SEC Form 4)
- Director Nachtsheim Jami K was granted 60,000 shares, increasing direct ownership by 29% to 268,362 units (SEC Form 4)
- Chief Operating Officer Jayaraman Vivek K sold $50,001 worth of shares (16,667 units at $3.00) as part of a pre-agreed trading plan, decreasing direct ownership by 1.00% to 1,656,707 units (SEC Form 4)
- Director Witney Frank was granted 60,000 shares, increasing direct ownership by 21% to 340,059 units (SEC Form 4)
- Director Gregory Dean A. was granted 60,000 shares, increasing direct ownership by 69% to 146,725 units (SEC Form 4)
- Director Shan Hua was granted 60,000 shares, increasing direct ownership by 45% to 192,386 units (SEC Form 4)
Latest TWTR
- NY Gov Hochul's Latest Crackdown On Illicit Cannabis Operations Has The Big Apple In Its Crosshairs
- Biden's Health Secretary Stalls On Completing Marijuana Review By 4/20
- As Twitter Moves Forward With Cannabis Advertising, Meta Really Should Get With The Program
- Elon Musk's Decision To Allow Cannabis Ads On Twitter: It's A New Frontier And Benzinga Is Part Of It
- Elon Musk Tweets A Simple Yet Powerful Pro-Marijuana Message, Reaches Millions Around The World
- Google Ads For Cannabis: New Policy Change To Allow Advertising In These States
- Boobs And Bud: Is It Time To Go Back To Tumblr? Weed Friendly Social Network Allows Nudity Again
- SEC Form 4: Agrawal Parag returned 927,806 shares to the company, closing all direct ownership in the company
- SEC Form 4: Gadde Vijaya returned 1,097,589 shares to the company, closing all direct ownership in the company
- SEC Form 4: Segal Ned D. returned 945,546 shares to the company, closing all direct ownership in the company